Akriveia Therapeutics, LLC

Biotechnology company · Skillman, New Jersey, United States

Akriveia Therapeutics, LLC is a biotechnology company headquartered in Skillman, New Jersey, United States. Its earliest recorded incorporation is in 2016. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2018.

Profile compiled from public records. Is this your company? Request a correction or update

Akriveia Therapeutics at a glance

Typebiotechnology company
HeadquartersSkillman, New Jersey, United States
Earliest incorporation on record2016
SEC CIK1676950

What does Akriveia Therapeutics do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $3 million sold (2018).

Frequently asked questions about Akriveia Therapeutics

Where is Akriveia Therapeutics headquartered?

Akriveia Therapeutics, LLC is headquartered in Skillman, New Jersey, United States.

What does Akriveia Therapeutics do?

Akriveia Therapeutics, LLC is a biotechnology company.

When was Akriveia Therapeutics founded?

The earliest incorporation on record for Akriveia Therapeutics, LLC is in 2016, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences